Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-056183

Chief Legal Officer sold 7,179 shares at $0.49 ($3,518)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Wilson Mark Andrew Chief Legal Officer 2023-11-17 Sale −7,179 $0.49 $3,518 243,780 D
Open-market sales · 7,179 sh · avg $0.49 · $3,518
Loading xslF345X05/doc4.xml…